Hemogenyx Pharmaceuticals PLC (HEMO) — Tangible Net Worth Ratio
Hemogenyx Pharmaceuticals PLC (HEMO) has a Tangible Net Worth Ratio of 44.1% as of December 2024. This metric is calculated by deducting intangible assets (GBX477.40K) from net assets (GBX853.49K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Hemogenyx Pharmaceuticals PLC (HEMO) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hemogenyx Pharmaceuticals PLC Tangible Net Worth Ratio (2015–2024)
This chart shows how Hemogenyx Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 9 annual periods from 2015 to 2024. As of December 2024, the ratio stands at 44.1%, reflecting net assets of GBX853.49K with intangible assets of GBX477.40K GBX. See Hemogenyx Pharmaceuticals PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Hemogenyx Pharmaceuticals PLC (2015–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Hemogenyx Pharmaceuticals PLC from 2015 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Hemogenyx Pharmaceuticals PLC market capitalisation.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 44.1% | GBX853.49K | GBX477.40K | GBX4.21 Million | ▼ -39.0 pp |
| 2023 | 83.1% | GBX2.78 Million | GBX470.17K | GBX6.11 Million | ▼ -3.3 pp |
| 2022 | 86.4% | GBX3.24 Million | GBX441.49K | GBX7.09 Million | ▼ -8.2 pp |
| 2021 | 94.6% | GBX8.17 Million | GBX441.49K | GBX8.52 Million | ▲ +23.7 pp |
| 2020 | 70.9% | GBX875.68K | GBX254.96K | GBX2.66 Million | ▼ -0.7 pp |
| 2018 | 71.6% | GBX959.17K | GBX272.75K | GBX2.30 Million | ▼ -16.4 pp |
| 2017 | 87.9% | GBX2.13 Million | GBX257.52K | GBX2.40 Million | ▲ +19.1 pp |
| 2016 | 68.8% | GBX903.71K | GBX281.58K | GBX1.05 Million | ▲ +271.6 pp |
| 2015 | -202.8% | GBX77.82K | GBX235.64K | GBX324.65K | — |